{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:31:10Z","timestamp":1787941870358,"version":"build-2784847793"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2007,9,25]],"date-time":"2007-09-25T00:00:00Z","timestamp":1190678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2007,11,7]]},"DOI":"10.1007\/s10096-007-0390-5","type":"journal-article","created":{"date-parts":[[2007,9,24]],"date-time":"2007-09-24T12:18:59Z","timestamp":1190636339000},"page":"937-940","source":"Crossref","is-referenced-by-count":8,"title":["Mediastinal mass mimicking a tumor in a patient with bladder cancer after bacillus Calmette-Guerin treatment"],"prefix":"10.1007","volume":"26","author":[{"given":"A.","family":"Somoskovi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Carlyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dormandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Salfinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,25]]},"reference":[{"key":"390_CR1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0041-3879(83)90038-7","volume":"64","author":"JM Grange","year":"1983","unstructured":"Grange JM, Gibson J, Osborn TW, Collins CH, Yates MD (1983) What is BCG? Tubercle 64:129\u2013139","journal-title":"Tubercle"},{"key":"390_CR2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0022-5347(01)69072-4","volume":"167","author":"JW Davis","year":"2002","unstructured":"Davis JW, Sheth SI, Doviak MJ, Schellhammer PF (2002) Superficial bladder carcinoma treated with bacillus Calmette-Guerin: progression-free and disease specific survival with minimum 10-year followup. J Urol 167:494\u2013500","journal-title":"J Urol"},{"key":"390_CR3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","volume":"55","author":"A Jemal","year":"2005","unstructured":"Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10\u201330","journal-title":"CA Cancer J Clin"},{"key":"390_CR4","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/01.ju.0000173919.28835.aa","volume":"174","author":"JA Martinez-Pineiro","year":"2005","unstructured":"Martinez-Pineiro JA, Martinez-Pineiro L, Solsona E, Rodriguez RH, Gomez JM, Martin MG, Molina JR, Collado AG, Flores N, Isorna S, Pertusa C, Rabadan M, Astobieta A, Camacho JE, Arribas S, Madero R (2005) Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial. J Urol 174:1242\u20131247","journal-title":"J Urol"},{"key":"390_CR5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.eururo.2005.05.004","volume":"48","author":"EC Boer de","year":"2005","unstructured":"de Boer EC, Rooyakkers SJ, Schamhart DH, de Reijke TM, Kurth KH (2005) BCG dose reduction by decreasing the instillation frequency: effects on local Th1\/Th2 cytokine responses in a mouse model. Eur Urol 48:333\u2013338","journal-title":"Eur Urol"},{"key":"390_CR6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1464-410X.1998.00720.x","volume":"82","author":"NA Mungan","year":"1998","unstructured":"Mungan NA, Witjes JA (1998) Bacille Calmette-Guerin in superficial transitional cell carcinoma. Br J Urol 82:213\u2013223","journal-title":"Br J Urol"},{"key":"390_CR7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1445-2197.1998.tb04768.x","volume":"68","author":"DL Paterson","year":"1998","unstructured":"Paterson DL, Patel A (1998) Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: review of complications and their treatment. Aust NZ J Surg 68:340\u2013344","journal-title":"Aust NZ J Surg"},{"key":"390_CR8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-5347(17)37316-0","volume":"147","author":"DL Lamm","year":"1992","unstructured":"Lamm DL, van der Meijden PM, Morales A, Brosman SA, Catalona WJ, Herr HW, Soloway MS, Steg A, Debruyne FM (1992) Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 147:596\u2013600","journal-title":"J Urol"},{"issue":"Suppl 1","key":"390_CR9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000052381","volume":"37","author":"P Rischmann","year":"2000","unstructured":"Rischmann P, Desgrandchamps F, Malavaud B, Chopin DK (2000) BCG intravesical instillations: recommendations for side-effects management. Eur Urol 37(suppl 1):33\u201336","journal-title":"Eur Urol"},{"key":"390_CR10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0022-5347(17)45606-0","volume":"135","author":"DL Lamm","year":"1986","unstructured":"Lamm DL, Stogdill VD, Stogdill BJ, Crispen RG (1986) Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer. J Urol 135:272\u2013274","journal-title":"J Urol"},{"key":"390_CR11","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0140-6736(73)90860-X","volume":"2","author":"JS Hunt","year":"1973","unstructured":"Hunt JS, Silverstein MJ, Sparks FC, Haskell CM, Pilch YH, Morton DL (1973) Granulomatous hepatitis: a complication of B.C.G. immunotherapy. Lancet 2:820\u2013821","journal-title":"Lancet"},{"key":"390_CR12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/ajcp\/61.6.747","volume":"61","author":"A Bodurtha","year":"1974","unstructured":"Bodurtha A, Kim YH, Laucius JF, Donato RA, Mastrangelo MJ (1974) Hepatic granulomas and other hepatic lesions associated with BCG immunotherapy for cancer. Am J Clin Pathol 61:747\u2013752","journal-title":"Am J Clin Pathol"},{"key":"390_CR13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/clinids\/17.2.228","volume":"17","author":"M Kristjansson","year":"1993","unstructured":"Kristjansson M, Green P, Manning HL, Slutsky AM, Brecher SM, von Reyn CF, Arbeit RD, Maslow JN (1993) Molecular confirmation of bacillus Calmette-Guerin as the cause of pulmonary infection following urinary tract instillation. Clin Infect Dis 17:228\u2013230","journal-title":"Clin Infect Dis"},{"key":"390_CR14","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0022-5347(01)68169-2","volume":"158","author":"S Tuncer","year":"1997","unstructured":"Tuncer S, Tekin MI, Ozen H, Bilen C, Unal S, Remzi D (1997) Detection of bacillus Calmette-Guerin in the blood by the polymerase chain reaction method of treated bladder cancer patients. J Urol 158:2109\u20132112","journal-title":"J Urol"},{"key":"390_CR15","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1128\/JCM.26.8.1501-1505.1988","volume":"26","author":"FG Witebsky","year":"1988","unstructured":"Witebsky FG, Keiser JF, Conville PS, Bryan R, Park CH, Walker R, Siddiqi SH (1988) Comparison of BACTEC 13A medium and DuPont isolator for detection of mycobacteremia. J Clin Microbiol 26:1501\u20131505","journal-title":"J Clin Microbiol"},{"key":"390_CR16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/344908","volume":"36","author":"OY Gonzalez","year":"2003","unstructured":"Gonzalez OY, Musher DM, Brar I, Furgeson S, Boktour MR, Septimus EJ, Hamill RJ, Graviss EA (2003) Spectrum of bacille Calmette-Guerin (BCG) infection after intravesical BCG immunotherapy. Clin Infect Dis 36:140\u2013148","journal-title":"Clin Infect Dis"},{"key":"390_CR17","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/S0264-410X(00)00369-8","volume":"19","author":"J Bedwell","year":"2001","unstructured":"Bedwell J, Kairo SK, Behr MA, Bygraves JA (2001) Identification of substrains of BCG vaccine using multiplex PCR. Vaccine 19:2146\u20132151","journal-title":"Vaccine"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-007-0390-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-007-0390-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-007-0390-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,26]],"date-time":"2020-04-26T18:57:24Z","timestamp":1587927444000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-007-0390-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,25]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,11,7]]}},"alternative-id":["390"],"URL":"https:\/\/doi.org\/10.1007\/s10096-007-0390-5","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,25]]}}}